Xiaoyun Li , Zhijuan Liao , Siyan Huo , Fangna Gu , Yong Yin , Xuanchu Ge
{"title":"Higher serum carotenoid concentrations are associated with lower mortality in adults with advanced cardiovascular-kidney-metabolic syndrome","authors":"Xiaoyun Li , Zhijuan Liao , Siyan Huo , Fangna Gu , Yong Yin , Xuanchu Ge","doi":"10.1016/j.nutres.2025.06.002","DOIUrl":null,"url":null,"abstract":"<div><div>This study aimed to investigate the associations between serum carotenoid concentrations and all-cause mortality among adults with advanced cardiovascular-kidney-metabolic (CKM) syndrome. Data were analyzed from 1285 adults aged ≥20 years with advanced CKM syndrome (stages 3 or 4), identified from the National Health and Nutrition Examination Survey 2001 to 2006 cohort. Five serum carotenoids were assessed as exposures, including α-carotene, β-carotene, lycopene, lutein/zeaxanthin, and total carotenoids. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs, while quantile g-computation (Qgcomp) regression was employed to examine the joint effects of all carotenoids. During a median follow-up of 11.8 years, 936 (72.8%) deaths were recorded. Age- and sex-standardized all-cause mortality rates decreased across increasing quartiles of several serum carotenoids, most notably lycopene, for which the mortality rate declined from 106.6 (95% CI: 90.1-123.1) per 1000 person-years in the lowest quartile to 62.4 (95% CI: 54.6-70.1) in the highest quartile. Adjusted for potential confounders, higher concentrations of α-carotene (HR = 0.64, 95% CI: 0.49-0.84), β-carotene (HR = 0.76, 95% CI: 0.61-0.95), lutein/zeaxanthin (HR = 0.75, 95% CI: 0.59-0.96), lycopene (HR = 0.63, 95% CI: 0.49-0.81), and total carotenoids (HR = 0.81, 95% CI: 0.66-1.00) were significantly associated with lower all-cause mortality, while no significant association was observed for β-cryptoxanthin. Qgcomp regression demonstrated a significant joint protective effect of serum carotenoids on all-cause mortality (HR = 0.87, 95% CI: 0.79-0.95, <em>P</em> < .01), with lycopene contributing the most to the overall protective effect. In conclusion, the joint effect of serum carotenoids was independently associated with lower all-cause mortality in adults with advanced CKM syndrome, with lycopene showing the strongest contribution among the 5 carotenoids studied.</div></div>","PeriodicalId":19245,"journal":{"name":"Nutrition Research","volume":"140 ","pages":"Pages 34-45"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0271531725000788","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
This study aimed to investigate the associations between serum carotenoid concentrations and all-cause mortality among adults with advanced cardiovascular-kidney-metabolic (CKM) syndrome. Data were analyzed from 1285 adults aged ≥20 years with advanced CKM syndrome (stages 3 or 4), identified from the National Health and Nutrition Examination Survey 2001 to 2006 cohort. Five serum carotenoids were assessed as exposures, including α-carotene, β-carotene, lycopene, lutein/zeaxanthin, and total carotenoids. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs, while quantile g-computation (Qgcomp) regression was employed to examine the joint effects of all carotenoids. During a median follow-up of 11.8 years, 936 (72.8%) deaths were recorded. Age- and sex-standardized all-cause mortality rates decreased across increasing quartiles of several serum carotenoids, most notably lycopene, for which the mortality rate declined from 106.6 (95% CI: 90.1-123.1) per 1000 person-years in the lowest quartile to 62.4 (95% CI: 54.6-70.1) in the highest quartile. Adjusted for potential confounders, higher concentrations of α-carotene (HR = 0.64, 95% CI: 0.49-0.84), β-carotene (HR = 0.76, 95% CI: 0.61-0.95), lutein/zeaxanthin (HR = 0.75, 95% CI: 0.59-0.96), lycopene (HR = 0.63, 95% CI: 0.49-0.81), and total carotenoids (HR = 0.81, 95% CI: 0.66-1.00) were significantly associated with lower all-cause mortality, while no significant association was observed for β-cryptoxanthin. Qgcomp regression demonstrated a significant joint protective effect of serum carotenoids on all-cause mortality (HR = 0.87, 95% CI: 0.79-0.95, P < .01), with lycopene contributing the most to the overall protective effect. In conclusion, the joint effect of serum carotenoids was independently associated with lower all-cause mortality in adults with advanced CKM syndrome, with lycopene showing the strongest contribution among the 5 carotenoids studied.
期刊介绍:
Nutrition Research publishes original research articles, communications, and reviews on basic and applied nutrition. The mission of Nutrition Research is to serve as the journal for global communication of nutrition and life sciences research on diet and health. The field of nutrition sciences includes, but is not limited to, the study of nutrients during growth, reproduction, aging, health, and disease.
Articles covering basic and applied research on all aspects of nutrition sciences are encouraged, including: nutritional biochemistry and metabolism; metabolomics, nutrient gene interactions; nutrient requirements for health; nutrition and disease; digestion and absorption; nutritional anthropology; epidemiology; the influence of socioeconomic and cultural factors on nutrition of the individual and the community; the impact of nutrient intake on disease response and behavior; the consequences of nutritional deficiency on growth and development, endocrine and nervous systems, and immunity; nutrition and gut microbiota; food intolerance and allergy; nutrient drug interactions; nutrition and aging; nutrition and cancer; obesity; diabetes; and intervention programs.